Tumor Profiling Market Size, Share & Trends Report

Tumor Profiling Market Size, Share & Trends Analysis Report By Technique (Genomics, Proteomics), By Technology, By Application (Personalized Cancer Medicine, Oncological Diagnostics, Research), By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-2-68038-625-7
Number of Report Pages: 100
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Tumor Profiling Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Tumor Profiling Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Tumor Profiling Market: Technique Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Tumor Profiling Market: Technique Movement Analysis, USD Million, 2023 & 2030
4.3. Genomics
4.3.1. Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Proteomics
4.4.1. Proteomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Metabolomics
4.5.1. Metabolomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Epigenetics
4.6.1. Epigenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Tumor Profiling Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Tumor Profiling Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Sequencing Techniques
5.3.1. Sequencing Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. NGS
5.3.2.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Sanger Sequencing
5.3.3.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Pyro Sequencing
5.3.4.1. Pyro Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. In Situ Hybridization
5.4.1. In Situ Hybridization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Immunohistochemistry
5.5.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. qPCR
5.6.1. qPCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Microarray
5.7.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Tumor Profiling Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Tumor Profiling Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Personalized Cancer Medicine
6.3.1. Personalized Cancer Medicine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Oncological Diagnostics
6.4.1. Oncological Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Research
6.5.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Cancer Research
6.5.2.1. Cancer Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Biomarker Discovery
6.5.3.1. Biomarker Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Tumor Profiling Market: Regional Estimates & Trend Analysis
7.1. Tumor Profiling Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Tumor Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Illumina, Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. QIAGEN
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Genomic Health
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Neogenomics Inc.
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Life Sciences
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Oxford Gene Technology
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Bruker Spatial Biology, Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Ribomed Biotechnologies Inc.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. GenomeDX
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Guardant Health
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. FOUNDATION MEDICINE, INC.
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.